PV-0373: Epigenetic and metabolic reprogramming as a target for prostate tumor radiosensitization

MLA

M. Cojoc, et al. “PV-0373: Epigenetic and Metabolic Reprogramming as a Target for Prostate Tumor Radiosensitization.” Radiotherapy and Oncology, vol. 123, May 2017, p. S201. EBSCOhost, https://doi.org/10.1016/s0167-8140(17)30815-0.

APA

M. Cojoc, Claudia Peitzsch, Anna Tyutyunnykova, & Anna Dubrovska. (2017). PV-0373: Epigenetic and metabolic reprogramming as a target for prostate tumor radiosensitization. Radiotherapy and Oncology, 123, S201. https://doi.org/10.1016/s0167-8140(17)30815-0

Chicago

M. Cojoc, Claudia Peitzsch, Anna Tyutyunnykova, and Anna Dubrovska. 2017. “PV-0373: Epigenetic and Metabolic Reprogramming as a Target for Prostate Tumor Radiosensitization.” Radiotherapy and Oncology 123 (May): S201. doi:10.1016/s0167-8140(17)30815-0.